E
ZyVersa Therapeutics, Inc. ZVSA
$0.7899 -$0.0111-1.39%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024
Revenue -- --
Total Other Revenue -- --
Total Revenue -- --
Cost of Revenue -- --
Gross Profit -- --
SG&A Expenses -10.33% -11.62%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses -17.59% -2.57%
Operating Income 17.59% 2.57%
Income Before Tax 12.81% 2.57%
Income Tax Expenses -- --
Earnings from Continuing Operations 13.11% 2.23%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income 13.11% 2.23%
EBIT 17.59% 2.57%
EBITDA 17.57% 2.57%
EPS Basic 26.61% 26.97%
Normalized Basic EPS 26.35% 27.23%
EPS Diluted 26.61% 26.97%
Normalized Diluted EPS 26.35% 27.23%
Average Basic Shares Outstanding 18.39% 33.88%
Average Diluted Shares Outstanding 18.39% 33.88%
Dividend Per Share -- --
Payout Ratio -- --
Weiss Ratings